Literature DB >> 4596237

Intravascular coagulation in liver disease.

M Verstraete, J Vermylen, D Collen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4596237     DOI： 10.1146/annurev.me.25.020174.002311

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  12 in total

1.  Disseminated intravascular coagulation with renal and liver damage as the predominant manifestations of recurrent relapses in systemic juvenile rheumatoid arthritis.

Authors:  D Schwartz; M Averbuch; A Pines; R Kornovsky; Y Levo
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Behaviour of 125I-fibrinogen and 131I-albumin in experimental galactosamine-induced hepatitis.

Authors:  I Mahn; H Merkel; E L Sattler; G Müller-Berghaus
Journal:  Gut       Date:  1977-07       Impact factor: 23.059

3.  Carcinoma of the prostate presenting as acute disseminated intravascular coagulation.

Authors:  D Grignon; D I Turnbull; R C Lohmann
Journal:  CMAJ       Date:  1986-10-01       Impact factor: 8.262

4.  Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.

Authors:  G Müller-Berghaus; C Reuter; U Bleyl
Journal:  Am J Pathol       Date:  1976-02       Impact factor: 4.307

5.  Fibrinolysis and the bleeding tendency in patients with hepatosplenic schistosomiasis.

Authors:  S A Omran; N A Hussein; A A Mohamed; A H el-Kaliouby; A T Hussein
Journal:  J Clin Pathol       Date:  1990-06       Impact factor: 3.411

6.  The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease.

Authors:  R Scherer; M Kabatnik; J Erhard; J Peters
Journal:  Intensive Care Med       Date:  1997-11       Impact factor: 17.440

7.  Antithrombin III concentrate in the treatment of fulminant hepatic failure.

Authors:  K Fujiwara; K Okita; K Akamatsu; H Abe; Y Tameda; T Sakai; N Inoue; K Kanai; N Aoki; H Oka
Journal:  Gastroenterol Jpn       Date:  1988-08

8.  Antithrombin III metabolism in patients with liver disease.

Authors:  E Knot; J W Ten Cate; H R Drijfhout; L H Kahlé; G N Tytgat
Journal:  J Clin Pathol       Date:  1984-05       Impact factor: 3.411

9.  Intravascular coagulation in acute liver failure in rats and its treatment with antithrombin III.

Authors:  K Fujiwara; I Ogata; Y Ohta; K Hirata; Y Oka; S Yamada; Y Sato; N Masaki; H Oka
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

10.  Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.

Authors:  J J Rodzynek; D Urbain; P Leautaud; P Wettendorff; A Delcourt
Journal:  Gut       Date:  1984-10       Impact factor: 23.059
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.